A new process of cancer prevention mediated through inhibition of tumor necrosis factor α expression

Cancer Research

Volumn 56, Issue 16, 1996, Pages 3711-3715

  Suganuma, Masami ^a   Okabe, Sachiko ^a   Sueoka, Eisaburo ^a   Iida, Naoyuki ^a,c   Komori, Atsumasa ^a   Kim, Seong Jin ^b   Fujiki, Hirota ^a  

^a SAITAMA CANCER CENTER   (Japan)

^b NATIONAL CANCER INSTITUTE   (United States)

^c TOKYO UNIVERSITY OF SCIENCE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CANVENTOL; COMPLEMENTARY DNA; EPIGALLOCATECHIN GALLATE; MESSENGER RNA; OKADAIC ACID; SARCOPHYTOL A; TAMOXIFEN; TERPENE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CANCER PREVENTION; CELL CULTURE; CELL STRAIN 3T3; CONTROLLED STUDY; DOSE RESPONSE; DRUG STRUCTURE; EARLY RESPONSE GENE; GENE EXPRESSION REGULATION; MOUSE; NONHUMAN; NORTHERN BLOTTING; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS;

3T3 CELLS; ANIMALS; ANTICARCINOGENIC AGENTS; BASE SEQUENCE; CATECHIN; CYCLOHEXANOLS; DITERPENES; HUMANS; MICE; MOLECULAR SEQUENCE DATA; PROTO-ONCOGENES; TAMOXIFEN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0029761399     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Sporn, M. B Chemoprevention of cancer. Lancet. 342: 1211-1213, 1993.
2. Komori, A., Yatsunami, J., Suganuma, M , Okabe, S , Abe, S , Sakai, A., Sasaki, K., and Fujiki, H. Tumor necrosis factor acts as a tumor promoter in BALB/3T3 cell transformation. Cancer Res., 53: 1982-1985, 1993.
3. Komori, A , Suganuma, M., Okabe, S., Zou, X., Tius, M. A , and Fujiki, H Canventol inhibits tumor promotion in CD-1 mouse skin through inhibition of tumor necrosis factor a release and of protein isoprenylation. Cancer Res., 53: 3462-3464, 1993.
4. Aggarwal, B. B., and Natarajan, K Tumor necrosis factors, developments during the last decade. Eur. Cytokine Netw., 7: 93-124, 1996.
5. Fujiki, H., Suganuma, M., Yoshizawa, S., Yatsunami, J., Nishiwaki, S., Furuya, H., Okabe, S., Nishiwaki, M. R., Matsunaga, S., Muto, Y , Okuda, T., and Sugimura, T. Sarcophytol A and (-)-epigallocatechin gallate (EGCG), nontoxic inhibitors of cancer development. In: L Wattenberg, M. Lipkin, C. W Boone, and G. J. Kelloff (eds), Cancer Chemoprevention, pp. 393-405. London: CRC Press, 1992
6. Sharma, S., Stutzman, J. D., Kelloff, G. J,. and Steele V. E. Screening of potential chemopreventive agents using biochemical markers of carcinogenesis. Cancer Res., 54: 5848-5855, 1994.
7. Biswas, D. K., Tius, M. A., Zhuo, J., and Pardee, A B. Canventol inhibits HIV-1 replication by a TAT-induced TAR-independent mechanism J. Acquired Immune Defic. Syndr., in press, 1996.
8. Fujiki, H., Yoshizawa, S., Horiuchi, T., Suganuma, M., Yatsunami, J., Nishiwaki, S., Okabe, S., Nishiwaki, M. R., Okuda, T., and Sugimura, T. Anticarcinogenic effects of (-)-epigallocatechin gallate. Prev. Med., 21: 503-509, 1992.
9. Taniguchi, S., Fujiki, H., Kobayashi, H., Go, H, Miyado, K., Sadano, H., and Shimokawa, R. Effect of (-)-epigallocatechin gallate, the main constituent of green tea, on lung metastasis with mouse B16 melanoma cell lines. Cancer Lett., 65: 51-54, 1992.
10. Jordan, V. C. The role of tamoxifen in the treatment and prevention of breast cancer Curr. Probl. Cancer, 16: 134-176, 1992.
11. Chomczynski, P., and Sacchi, N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem., 162: 156-159, 1987
12. Sueoka, E., Suganuma, M., Okabe, S., Komori, A , Kozu, T , Uemura, D., Ohta. T., and Fujiki, H. Expression of early response genes and of tumor necrosis factor-α gene by the okadaic acid class tumor promoters in relation to carcinogenesis. In: Y. Hokama. P. J Scheuer, and T. Yasumoto (eds.), Proceedings of the International Ciguatera and Marine Natural Products, pp 183-196. Honolulu, Hawaii: Asian-Pacific Research Foundation, 1995.
13. Ohta, T., Sueoka, E., Iida, N., Komori, A., Suganuma, M., Nishiwaki, R , Tatematsu, M., Kim, S-J., Carmichael, W. W , and Fujiki, H. Nodularin, a potent inhibitor of protein phosphatases 1 and 2A, is a new environmental carcinogen in male F344 rat liver. Cancer Res., 54: 6402-6406, 1994
14. El-Bayoumy, K. Evaluation of chemopreventive agents against breast cancer and proposed strategies for future clinical intervention trials. Carcinogenesis, 15: 2395-2420, 1994.
15. Angel, P., and Karin, M The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. Biochim. Biophys. Acta, 1072: 129-157, 1991.
16. Kock, A., Schwarz, T , Kirnbauer, R., Urbanski, A , Perry, P , Ansel, J. C , and Luger, T A. Human keratinocytes are a source for tumor necrosis factor α: evidence for synthesis and release upon stimulation with endotoxin or ultraviolet light. J Exp Med., 172: 1609-1614, 1990.
17. Sueoka, E , Nishiwaki, S , Okabe, S., Iida, N., Suganuma, M , Yano, I., Aoki, K., and Fujiki, H Activation of protein kinase C by mycobacterial cord factor, trehalose 6-monomycolate, resulting in tumor necrosis factor-α release in mouse lung tissues. Jpn. J. Cancer Res., 86: 749-755, 1995
18. Sugarman, B J , Aggarwal, B. B., Hass, P. E , Figari, I. S., Palladino Jr., M A , and Shepard, H M. Recombinant human tumor necrosis factor-α effects on proliferation of normal and transformed cells in vitro. Science (Washington DC), 230: 943-945, 1985.
19. Gelin, J., Moldawer, L. L., Lönnroth, C , Sherry, B., Chizzonite, R., and Lundholm, K. Role of endogenous tumor necrosis factor a and interleukin 1 for experimental tumor growth and the development of cancer cachexia. Cancer Res , 51: 415-421, 1991
20. Wu, S., Boyer, C. M., Whitaker, R S., Berchuck, A , Wiener, J R , Weinberg, J. B., and Bast, R. C., Jr. Tumor necrosis factor a as an autocrine and paracrine growth factor for ovarian cancer: monokine induction of tumor cell proliferation and tumor necrosis factor α expression. Cancer Res., 53: 1939-1944, 1993.
21. Orosz, P., Echtenacher, B , Falk, W., Rüschoff, J., Weber, D., and Männel, D. N. Enhancement of experimental metastasis by tumor necrosis factor. J. Exp. Med., 177: 1391-1398, 1993.
22. Rieckmann, P, Thévenin, C., and Kehrl, J. H. Okadaic acid is a potent inducer of AP-1, NF-κB and tumor necrosis factor-α in human B lymphocytes Biochem. Biophys. Res. Commun., 187: 51-57, 1992.
23. Sung, S-s J., Walters, J. A., and Fu, S. M. Stimulation of tumor necrosis factor a production in human monocytes by inhibitors of protein phosphatase 1 and 2A. J. Exp. Med., 176: 897-901, 1992
24. Xia, H-Z., Kannapell, C. C., Fu, S. M., and Sung. S-s. J. Differential regulation of human B-lymphocyte tumor necrosis factor-α (TNF-α) and lymphotoxin (TNF-β) production by protein phosphatase 1 and 2A inhibitor. Blood, 82: 2806-2812, 1993.
25. Kopp, E., and Ghosh, S. Inhibition of NF-κB by sodium salicylate and aspirin Science (Washington DC), 265: 956-959, 1994.
26. Frantz, B., O'Neill, E. A., Ghosh, S., and Kopp, E The effect of sodium salicylate and aspirin on NF-κB. Science (Washington DC), 270: 2017-2019, 1995.
27. Scheinman, R. I, Cogswell, P. C., Lofquist, A. K , and Baldwin, A. S., Jr Role of transcnptional activation of IκBα in mediation of immunosuppression by glucocorticoids. Science (Washington DC), 270; 283-286, 1995.
28. Auphan, N , DiDonato, J. A., Rosette, C., Helmberg, A , and Kann, M. Immunosuppression by glucocorticoids: inhibition of NF-κB activity through induction of IκB synthesis. Science (Washington DC), 270: 286-290, 1995.
29. Thun, M. J., Namboodiri, M N., and Heath, C. W. Aspirin use and reduced risk of fatal colon cancer N Engl. J. Med., 325: 1593-1596, 1991.
30. Gearing, A. J H., Becken, P , Christodoulou, M., Churchill, M , Clements. J , Davidson, A H., Drummond, A. H., Galloway, W. A., Gilbert, R., Gordon, J. L , Leber, T M., Mangan, M , Miller, K., Nayee, P , Owen, K., Patel, S., Thomas, W., Wells, G , Wood, L. M., and Woolley, K. Processing of tumour necrosis factor-α precursor by metalloproteinases. Nature (Lond.), 370 555-557, 1994.
31. McGeehan, G. M., Becherer, J. D., Bast, R. C., Jr., Boyer, C. M., Champion, B., Connolly, K M, Conway, J. G., Furdon, P., Karp, S., Kidao, S., McElroy, A. B , Nichols, J., Pryzwansky, K. M., Schoenen, F., Sekut, L., Truesdale, A., Verghese, M , Warner, J., and Ways, J. P. Regulation of tumour necrosis factor-α processing by a metalloproteinase inhibitor. Nature (Lond.), 370 558-561, 1994.
32. Popik, W., and Pitha, P M. Role of tumor necrosis factor alpha in activation and replication of the rat-defective human immunodeficiency virus type 1. J. Virol., 67: 1094-1099, 1993.